Electra Therapeutics Inc ETRA

$8.75 0.00 (—)

Valuation

Market cap
549,211,000
Revenue TTM
$0
Net income TTM
$-61,975,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
1,380,400
Avg volume
—
Day's range
$8.50 – $9.15
Shares out
62,767,000
Stochastic %K
15%
Beta
—
Analysts
Strong Sell
Price target
$34.00

Price

Company profile

Electra Therapeutics, Inc. is a clinical-stage biotechnology company. It develops therapies that target signal regulatory proteins for the treatment of novel targets for diseases in immunology and cancer. Its product, ELA026, is a monoclonal antibody that targets signal regulatory protein on the cell surface of myeloid and T cells and depletes pathological immune cells, enabling medical professionals to find an appro...

Show more

Electra Therapeutics, Inc. is a clinical-stage biotechnology company. It develops therapies that target signal regulatory proteins for the treatment of novel targets for diseases in immunology and cancer. Its product, ELA026, is a monoclonal antibody that targets signal regulatory protein on the cell surface of myeloid and T cells and depletes pathological immune cells, enabling medical professionals to find an approved treatment for secondary hemophagocytic lymphohistiocytosis, a life-threatening hyperinflammatory condition. The company was incorporated in 2018 and is based in South San Francisco, California.

Industry
Biotechnology
Sector
Healthcare
Phone
(888) 743-2290
Website
https://electra-therapeutics.com
Address
230 E Grand Avenue, Suite S-100, South San Francisco, United States

Latest news

Stocktwits

SemperFidelity Oct 14, 6:21 PM
$ETRA see how this ages …🍷
0 replies
justiceforb_85 Sep 23, 1:00 AM
$ETRA significantly undervalued based on current MC based on the data presented for ipsoprubart in sHLH and the potential for treatment of T/NK cell lymphomas.
1 replies
theflynews Sep 21, 8:03 PM
Opening Day: Electra Therapeutics, Orion180 make market debuts - $ETRA - https://thefly.com/ETRA
0 replies
IPOtweet Sep 18, 11:29 PM
US IPO Weekly Recap: Data center developer Nscale files, while Holtec Nuclear postpones IPO $NSCL $HNUC $ETRA $OIG $ASBH $IPO #IPO https:/
0 replies
titanmaximum2 Sep 18, 6:15 PM
$ETRA I got shut out from Fidelity again on an IPO. This time I'm glad. I got in cheaper.
1 replies
notreload_ai Sep 18, 4:35 PM
BREAKING: Electra Therapeutics $ETRA opens at $15, the same price as its IPO.
0 replies
justiceforb_85 Sep 18, 4:34 PM
$ETRA ipsoprubart with compelling data in sHLH and outstanding data in T cell lymphoma. Starting a position.
0 replies
notreload_ai Sep 18, 3:44 PM
BREAKING: Electra Therapeutics $ETRA indicated to open at $20, after pricing its IPO at $15.
0 replies